17
| 3 | 2012
Klinisk Biokemi i Norden
19.
Rosenfield RL. Clinical practice. Hirsutism. N
Engl J Med 2005;353:2578-2588.
20.
Azziz R, Woods KS, Reyna R, Key TJ, Kno-
chenhauer ES et. al. The prevalence and
features of the polycystic ovary syndrome in
an unselected population. J Clin Endocrinol
Metab 2004;89:2745-9.
21.
Rotterdam ESHRE/ASRM-Sponsored PCOS
Consensus Workshop Group. Revised 2003
consensus on diagnostic criteria and long-
term health risks related to polycystic ovary
syndrome. Fertil Steril 2004;81:19-25.
22.
Azziz R, Carmina E, Dewailly D, Diamanti-
Kandarakis E, Escobar-Morreale HF et. al.
Position statement: Criteria for defining poly-
cystic ovary syndrome as a predominantly
hyperandrogenic syndrome: An Androgen
Excess Society guideline. J Clin Endocrinol
Metab 2006;91:4237-45.
23.
Skakkebæk NE, Juul A, Jørgensen N, Rajpert-
De Meyts E. Andrologisk endokrinologi.
In: Hansen NE, Haunsø S, Schaffalitzky de
Muckadell OB, eds. Medicinsk Kompendium,
16.
udg. København: Nyt Nordisk Forlag
Arnold Busck A/S, 2004;2188-213.
24.
Juul A, Hagen C, Aksglaede L, Sørensen K,
Mouritsen A et. al. Endocrine evaluation of
reproductive function in girls during infancy,
childhood and adolescence. In: Sultan C, ed.
Pediatric and Adolescent Gynecology. Evi-
dence-based Clinical Practice. 2nd ed. Endocr
Dev Basel: Karger, 2012;22:1-16.
Fotnot: Denna aktikel har tidigare tryckts i DSKB-Nyt.
Foto: Ingunn Þorsteinsdóttir, Island.
